DCMM
EW icon

DG Capital Management (Massachusetts)’s Edwards Lifesciences EW Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.74M Buy
68,250
+28,200
+70% +$1.06M 2.7% 8
2016
Q2 		$1.33M Buy
+40,050
New +$1.37M 1.42% 30

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DG Capital Management (Massachusetts)'s EW Position: Q3 2016 in Review

DG Capital Management (Massachusetts) increased its Edwards Lifesciences (EW) stake by 70% in Q3 2016, buying an estimated $1.06M and bringing the position to 68,250 shares worth $2.74M. The position accounts for 2.7% of the portfolio, ranked #8.

DG Capital Management (Massachusetts) first reported a position in EW in Q2 2016 and has held it in 2 quarters since. 693 funds tracked by Wall St. Rank hold EW as of Q3 2016.

  • DG Capital Management (Massachusetts) held 68,250 shares of Edwards Lifesciences worth $2.74M as of Q3 2016.
  • DG Capital Management (Massachusetts) bought 28,200 Edwards Lifesciences shares in Q3 2016, an estimated $1.06M.
  • Edwards Lifesciences made up 2.7% of DG Capital Management (Massachusetts)'s portfolio in Q3 2016, its #8 holding.
  • DG Capital Management (Massachusetts) first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 2 quarters since.
  • 693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.